Day :
Keynote Forum
Gulten Kaptan
Istanbul Arel University, Turkey
Keynote: An Important Part of Cancer Care in Turkey
Time : 10:25-10:50
Biography:
Gülten Kaptan done her Nursing from Hacettepe University Institute of Health Sciences in the field of Internal Medicine in year of 1997.2005 in the year received the title of associate professor in the same area, has been professor in 2012. Many articles in international journals in the field served as a faculty member. Prof.Kaptan,30 years, has made college and university health research and practice serves as a director of nursing at the hospital. That the author published in Turkish and internal school used as a textbook in health and geriatric diseases are nursing books. Euthanasia, pain and spritüalizm,violence in pregnancy have been published by titles in international book in English. Scientific board member one of the international open access journal. The scientific committee membership in Turkish health journals about nursing. In Turkey ,She is the Turkish Nurses Association, Oncology Nursing Society and Nephrology Nursing associations member. Currently, Istanbul Arel University Medical Nursing is a Professor.
Abstract:
Cancer often causes symptoms, and the treatments for cancer may cause side effects. An important part of cancer care is relieving these symptoms and side effects, an approach called palliative care. Palliative care is any treatment that focuses on reducing a patient’s symptoms, improving quality of life, and supporting patients and their families. In order to anticipate the increasing need for care correctly, experts believe that it is important to have a proactive approach right at the start of the palliative care continuum. Opioid preparations are available for patients at the end of life. Turkey has a colour coded prescription system; red prescription sheets for opioids, green for sedatives and opioid derivatives like Tramadol. White prescription sheets are used for all other drugs. In Turkey, only Specialist Medical Doctor has capability of using red and green prescription sheet. There is no Turkish hospice palliative care association yet, but it is set up as a subgroup for working palliative care nurses, as a brunch of Turkish Oncology Nursing Association. To carry out the control services of cancer, to provide the coordination and inspection studies of organizations and institutions giving service in this field.
Keynote Forum
Esther Ching-Lan Lin
National Cheng Kung University (NCKU) and Hospital, Taiwan
Keynote: Prevalence, gender differences, and risk factors of metabolic syndrome in Han-Chinese with schizophrenia taking second-generation antipsychotics in Taiwan
Time : 10:00-10:30
Biography:
Esther Ching-Lan Linis an Associate Professor in the Department of Nursing, College of Medicine, National ChengKung University, and adjunct Head Nurse of the Department of Psychiatry, National ChengKung University Hospital, Tainan, Taiwan. She has been a nurse, a manager, a teacher, and an advisor for 18 years. After completing her PhD at National Taiwan University. She continued her academic career in nursing education and has focused on improving the quality of care for patients with severe mental illness. She has published 30 papers in English-language and Chinese-language journals—most recently on developing and evaluating psychosocial treatments for patients with schizophrenia and bipolar disorder—and has been an editorial board member for the past 3 years of a national nursing journal in Taiwan.
Abstract:
Accumulating evidence supports an association between metabolic alterations and schizophrenia (Aichhorn et al. 2006; Kraemer et al. 2011). It is estimated that nearly two thirds of patients with schizophrenia have obesity (Keltner 2006; Rummel-Kluge et al. 2010), and metabolic syndrome (MetS) (De Hert et al. 2009; Saddichha et al. 2007). The prevalence in schizophrenic patients is nearly triple that of the general population (Association, American Diabetes et al. 2004). We examined the prevalence, gender differences, and risk factors for metabolic syndrome of patients with schizophrenia using second-generation antipsychotics. A cross-sectional sample of 329 patients was recruited in central Taiwan. Prevalence was estimated using the definitions of the International Diabetes Federation for Chinese. Logistic regression analyses were done to assess the predictive power of demographic and clinical risk factors for metabolic syndrome, and to identify gender-specific predictors. The prevalence of metabolic syndrome was 23.7% (n = 78; men = 25.7% vs. women = 21.2%). Risk factors were a body mass index (BMI) greater than 24 and abnormal non-HDL-C (≥ 130 mg/dL). Gender-specific risk factors and related mechanisms are discussed. Future development of specific interventions for metabolic syndrome is imperative for early identification and prevention.